The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.70
Bid: 11.00
Ask: 12.80
Change: -1.30 (-9.85%)
Spread: 1.80 (16.364%)
Open: 12.00
High: 12.00
Low: 11.70
Prev. Close: 13.20
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

10 Jul 2012 13:47

RNS Number : 3074H
Carclo plc
10 July 2012
 



Carclo plc

 

("Carclo" or "the Company" or "the Group")

 

Issue of Equity - Placing to raise £13.3 million

 Directors' Dealings

 

10 July 2012

 

 

Further to the announcement of 9 July 2012, the Board of Carclo is pleased to announce the successful completion of the cash placing with institutional investors (the "Placing") of 3,078,240 new ordinary shares of 5 pence each in the Company ("Placing Shares") at a subscription price of 431 pence per share (the "Placing Price"). The Placing Shares will equate to approximately 4.98 per cent. of the current issued share capital of the Company and immediately following the Placing the Company's issued share capital will consist of 64,877,942 ordinary shares of 5 pence each ("ordinary shares").

 

The proceeds raised from the Placing will amount to approximately £13.3 million before expenses and such proceeds will be used to fund future capital investment in Conductive Inkjet Technology ("CIT") and the development of Carclo Diagnostic Solutions ("CDS"), and to reduce Group indebtedness.

 

Directors' share sales

 

In order to satisfy investor demand, two directors, who have previously announced their intention to retire, Mr Ian Williamson, Chief Executive Officer, and Mr Christopher Ross, Chairman, agreed on 9 July 2012 to sell 230,000 ordinary shares and 25,000 ordinary shares, respectively. In order that the total cost to the acquirers, including stamp duty, of such ordinary shares was the same as the subscription cost of the Placing Shares (the issue of which by the Company is not liable to stamp duty), these trades, which are subject to the same conditions as the Placing, were entered into at a price of 428.86 pence per ordinary share.

 

Mr Williamson's disposal represents approximately one third of his total holding, which is held within his personal pension plan, and is intended to facilitate his retirement as Chief Executive Officer in March 2013. He has no plans for any further share disposals from his current holding. Christopher Ross's disposal of shares precedes his retirement as Chairman of the Company in September 2012.

 

Application for listing and admission to trading

 

The Placing Shares will be issued fully paid and will rank pari passu in all respects with the existing ordinary shares. Application has been made to the Financial Services Authority for admission of the Placing Shares to the Official List maintained by the UK Listing Authority and to the London Stock Exchange (the "LSE") for admission to trading of the Placing Shares on the LSE's main market for listed securities (together "Admission"). It is expected that Admission will take place at 8.00 am on 12 July 2012 and that dealings in the Placing Shares on the LSE's main market for listed securities will commence at the same time.

 

The Placing remains subject to certain conditions, including:

 

·; Admission occurring not later than 8.00 am on 18 July 2012 (or such later time and / or date, being not later than 8.00 am on 23 July 2012, as the Company and Nplus1 Brewin LLP ("N+1 Brewin") may agree); and

·; the placing agreement which has been entered into by the Company and N+1 Brewin not having been terminated prior to Admission.

 

N+1 Brewin acted as sole bookrunner in respect of the Placing, supported by Liberum Capital.

 

 

Carclo plc 01924 268040

Ian Williamson, Chief Executive

Robert Brooksbank, Finance Director

 

N+1 Brewin 0131 529 0356

Nick Tulloch

Joe Stroud

 

Weber Shandwick Financial 020 7067 0700

Nick Oborne

Stephanie Badjonat

Robert Cook

 

This announcement and the information contained herein is not for publication, release or distribution, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction in which the same would be unlawful. This announcement does not constitute an offer to sell or issue, or the solicitation of an offer to buy or acquire, shares in the capital of the Company in the United States, Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction in which such an offer or solicitation is unlawful. The Placing Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") and may not be offered, sold or transferred, directly or indirectly, within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and the securities laws of any state or other jurisdiction of the United States. There will be no public offer of the Placing Shares in the United States, the United Kingdom or elsewhere.

This announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made by N+1 Brewin or by any of its affiliates or agents as to, or in relation to, and no responsibility or liability is or will be accepted by N+1 Brewin or by any of its affiliates or agents as to or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefor is expressly disclaimed.

N+1 Brewin, which is authorised and regulated by the Financial Services Authority, is acting for the Company in connection with the Placing and no-one else and will not be responsible to anyone other than the Company (whether or not a recipient of this announcement) for providing the protections afforded to clients of N+1 Brewin or for providing advice in relation to the Placing.

The distribution of this announcement and the offering of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken by the Company or N+1 Brewin that would permit an offering of such shares or possession or distribution of this announcement or any other offering or publicity material relating to such shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Company and N+1 Brewin to inform themselves about, and to observe, such restrictions.

Certain statements in this announcement are forward-looking statements which are based on the Company's current expectations, intentions and projections regarding its future performance, currently anticipated events or trends and other matters that are not historical facts. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. The information contained in this announcement is subject to change without notice and neither the Company nor N+1 Brewin assumes any responsibility or obligation to update publicly or review any of the forward-looking statements contained herein.

Any indication in this announcement of the price at which ordinary shares have been bought or sold in the past cannot be relied upon as a guide to future performance. No statement in this announcement is intended to be a profit forecast and no statement in this announcement should be interpreted to mean that earnings per share of the Company for the current or future financial years will necessarily match or exceed the historical published earnings per share of the Company.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEVBLBFLDFXBBD
Date   Source Headline
30th Apr 20247:00 amRNSHolding(s) in Company
30th Apr 20247:00 amRNSHolding(s) in Company
26th Apr 20247:00 amRNSTrading Statement
17th Apr 20247:55 amRNSDirectorate Change
15th Apr 20243:55 pmRNSHolding(s) in Company
28th Feb 20247:00 amRNSDirectorate Change
14th Feb 20247:00 amRNSStrategic Consolidation & Tucson Facility Closure
9th Feb 20241:15 pmRNSHolding(s) in Company
29th Jan 202411:09 amRNSDirectorate Change
23rd Jan 20244:48 pmRNSHolding(s) in Company
6th Dec 202310:53 amRNSHolding(s) in Company
30th Nov 20237:00 amRNSHalf-year Report
16th Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
25th Oct 20233:16 pmRNSCarclo Strategic Decision to Close Derry Facility
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
31st Aug 20234:01 pmRNSResult of AGM
31st Aug 20237:00 amRNSTrading Update
21st Aug 20231:09 pmRNSDirectorate Change
31st Jul 202311:42 amRNSAnnual Financial Report
18th Jul 20237:00 amRNSBanking covenant update
12th Jul 20237:00 amRNSFinal Results
7th Jul 20237:00 amRNSNotice of Investor Meet Presentation
23rd Jun 20237:00 amRNSBanking covenant adjustment
21st Jun 20231:08 pmRNSNotice of Results
30th May 202310:07 amRNSUpdate on contract cancellation
17th May 20238:46 amRNSHolding(s) in Company
12th May 20239:38 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSTrading Statement
31st Mar 202312:50 pmRNSBanking Covenant update
9th Mar 20239:56 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSDirectorate Change
6th Jan 20234:17 pmRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20221:15 pmRNSDirector/PDMR Shareholding
16th Dec 20221:11 pmRNSDirector/PDMR Shareholding
16th Dec 20221:10 pmRNSDirector/PDMR Shareholding
15th Dec 20227:00 amRNSTrading Update
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20229:44 amRNSContract Cancellation
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.